iifl-logo

Medicamen Biotech Ltd Cash Flow Statement

458.45
(-2.34%)
Apr 23, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Medicamen Biotec FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

16.75

16.6

13.9

6.35

Depreciation

-2.51

-2.49

-2.05

-1.92

Tax paid

-4.26

-4.34

-3.78

-1.19

Working capital

-1.38

-8.09

38.28

6.51

Other operating items

Operating

8.57

1.65

46.33

9.74

Capital expenditure

57.92

11.96

8.12

1.87

Free cash flow

66.49

13.61

54.45

11.61

Equity raised

219.91

161.43

70.23

19.54

Investing

0

1.99

0

0.05

Financing

10.35

-2.81

-1

0.51

Dividends paid

0

0

0

0

Net in cash

296.76

174.23

123.69

31.72

Medicamen Biotec : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.